Key Points
- Nova Capital Management has acquired the BMP Group of companies and RB Medical from Andrew Industries in a transaction announced on 2 October 2026.
- The financial terms of the acquisition have not been disclosed.
- BMP Group is a global manufacturer of industrial consumable components and sub-assemblies.
- BMP Group serves industrial and specialist markets including office automation, filtration, automotive, domestic appliances, sustainable tree protection and renewable energy.
- RB Medical is a specialised healthcare products business serving the UK medical sector.
- Andrew Industries is a privately owned multinational manufacturing group founded in 1894, with its head office in Lancashire, UK.
- Nova Capital Management said it intends to support the acquired businesses through continued investment, operational improvement, product innovation and long-term growth.
- Existing management structures will remain in place, with Nova providing additional strategic, financial and operational support.
- Nova Partner Omiros Millas and Nova Operating Partner Carl Francis will jointly oversee BMP Group and RB Medical on behalf of Nova.
- Nova said it sees opportunities for greater collaboration across the businesses while maintaining their existing capabilities and customer relationships.
- Andrew Industries CEO Mark Bennett said the businesses had been important parts of the group and described Nova as the long-term owner for their next phase of development.
- Nova was advised by Dentons and Cooper Parry on legal matters, Grant Thornton on financial and tax matters, and Fellwood Advisory on debt structuring.
- Andrew Industries’ shareholders were advised by KPMG Corporate Finance, with DLA Piper acting as legal adviser.
- KPMG Head of UK Diversified Industrials M&A Surinderpal Matharu said KPMG had advised Andrew Industries’ shareholders on the transaction.
Nova Capital Management has acquired the BMP Group of companies and RB Medical from Andrew Industries, adding two specialised businesses spanning industrial manufacturing and UK healthcare products to its portfolio. The transaction, announced on 2 October 2026, comes with no disclosed purchase price, while Nova has said the businesses will retain their existing management structures and receive additional strategic, financial and operational support. Andrew Industries, whose head office is in Lancashire, UK, described the transaction as the next stage of development for the businesses, while Nova said its plans include further investment, operational improvement, product innovation and long-term growth.
What has Nova Capital Management acquired from Andrew Industries?
Nova Capital Management has acquired the BMP Group of companies and RB Medical from Andrew Industries, according to the announcement issued by Nova and distributed through GlobeNewswire and carried by Yahoo Finance.
The announcement was dated 2 October 2026 and datelined London and Chicago. Nova Capital Management described itself as a private equity firm focused on acquiring and growing industrial and specialised manufacturing businesses. The transaction’s financial terms were not disclosed.
The acquisition brings together two businesses with different but complementary operating profiles.
BMP Group is described as a global manufacturer of industrial consumable components and sub-assemblies. Its activities cover a range of industrial and specialist applications, including office automation, filtration, automotive, domestic appliances, sustainable tree protection and renewable energy.
RB Medical, meanwhile, is a specialised healthcare products business serving the UK medical sector.
According to the transaction announcement, both businesses operate across multiple international locations and have developed longstanding customer relationships, technical expertise and reputations for quality, innovation and operational reliability.
Why are BMP Group and RB Medical significant to the transaction?
The businesses bring established industrial and specialist capabilities into Nova’s portfolio.
BMP Group’s exposure to several industrial end markets gives the business a broad operating base. Its stated markets include automotive, filtration, office automation, domestic appliances, sustainable tree protection and renewable energy.
That combination means the company is not described as serving a single industrial application. Instead, its product portfolio spans several areas where specialised components and sub-assemblies are required.
RB Medical adds a different dimension to the acquisition through its focus on healthcare products for the UK medical sector.
The source announcement says both businesses have longstanding customer relationships and deep technical expertise. Nova has indicated that these existing capabilities and relationships will be retained as part of its approach following the acquisition.
What did Nova Capital Management say about the acquisition?
As reported by Yahoo Finance from the GlobeNewswire announcement issued by Nova Capital Management, David Williamson, Founder and Managing Partner of Nova, said the firm was pleased to welcome BMP Group and RB Medical into its portfolio.
Williamson highlighted the businesses’ technical capabilities, customer relationships and management teams.
He also said Nova sees opportunities to build on the foundations established by the businesses through continued investment, operational improvement, product innovation and long-term growth.
The comments indicate that Nova’s stated strategy is not based on replacing the operating structures immediately. Instead, the private equity firm plans to work from the businesses’ existing capabilities while providing additional resources and investment.
The acquisition therefore combines ownership change with an operating strategy centred on development and investment.
How will Nova manage BMP Group and RB Medical after the acquisition?
Nova has said the existing management structures will remain in place.
Omiros Millas, Partner at Nova, said the quality of the businesses and the people behind them were a key attraction. According to the GlobeNewswire announcement, Millas said Nova would work closely with the existing management teams while preserving the capabilities and customer relationships that had contributed to the businesses’ development.
Millas also identified opportunities for additional resources, investment, and focus to support the businesses’ development.
The announcement further states that Omiros Millas and Carl Francis, Nova Operating Partner, will jointly be responsible for BMP Group and RB Medical on behalf of Nova.
Their responsibilities will include working with the individual management teams on strategy, performance, investment and business development.
This structure places Nova’s investment and operating capabilities alongside the experience of the existing leadership teams.
What is Nova’s strategy for future growth?
Nova has positioned the transaction within its broader strategy of investing in specialised industrial, manufacturing and business services companies.
According to the company’s announcement, Nova focuses on businesses with strong market positions, technical differentiation and long-term growth potential.
The firm said the newly acquired businesses could benefit from continued investment, operational improvements and product innovation.
Another element highlighted by Nova is potential collaboration across the businesses. Omiros Millas said the firm sees opportunities both within the individual businesses and through greater collaboration across the group.
The statement does not provide specific financial targets or disclose a detailed investment timetable. It instead outlines a general strategy of supporting the businesses while maintaining their existing operating capabilities.
What did Andrew Industries say about the sale?
Mark Bennett, CEO of Andrew Industries, said BMP Group and RB Medical had been important parts of Andrew Industries and praised what their teams had accomplished.
As reported in the GlobeNewswire announcement, Bennett said Andrew Industries believed Nova Capital Management was the long-term owner to support the businesses through their next phase of development and growth.
Bennett also pointed to Nova’s operational expertise, investment capability and partnership approach.
Andrew Industries said the transaction would support continued development for employees, customers and stakeholders.
The comments provide the seller’s perspective on the corporate transaction and indicate that the sale represents a change in ownership rather than an immediate restructuring of the businesses’ existing management arrangements.
What is Andrew Industries and where is it based?
Andrew Industries is a privately owned multinational manufacturing group founded in 1894.
The transaction announcement states that the company’s head office is based in Lancashire, UK. Its remaining businesses are focused on manufacturing and distributing technical nonwoven materials, and nonwoven felts and ancillary products for industrial laundry processes.
The Lancashire headquarters provides a direct UK corporate connection to the transaction.
Although Nova Capital Management is an international private equity firm with operations and investments beyond the UK, the seller is a long-established UK-headquartered manufacturing group, while RB Medical serves the UK medical sector.
That makes the transaction relevant to the wider UK corporate landscape, particularly in manufacturing, private equity and specialised industrial businesses.
Which advisers worked on the transaction?
Several professional services firms advised the parties involved in the acquisition.
According to the transaction announcement, Nova Capital Management was advised by Dentons and Cooper Parry on legal matters. Grant Thornton provided financial and tax advice, while Fellwood Advisory advised on debt structuring.
The shareholders of Andrew Industries were advised by KPMG Corporate Finance, with DLA Piper acting as legal adviser.
Surinderpal Matharu, KPMG Head of UK Diversified Industrials M&A, said KPMG was pleased to have advised the shareholders of Andrew Industries on the transaction.
Matharu said Nova represented an appropriate home for BMP Group and RB Medical and expressed his wishes for the management teams and employees during their next phase of growth.
The involvement of legal, financial, tax and debt advisers illustrates the range of professional disciplines typically involved in a private-equity acquisition involving established manufacturing businesses.
How large is Nova Capital Management’s investment portfolio?
Nova Capital Management describes itself as an international private equity firm focused on acquiring and growing industrial, manufacturing and business services companies.
According to the company’s transaction announcement, Nova was founded in 2002 and has invested in more than 75 businesses through transactions with a combined value of more than £2 billion.
The company says it partners closely with management teams to support operational excellence, long-term value creation and sustainable growth.
The BMP Group and RB Medical acquisition therefore forms part of Nova’s stated strategy of investing in specialised businesses rather than representing a move into an entirely new investment model.
What happens to BMP Group and RB Medical following the acquisition?
The businesses will continue operating under their existing management structures, according to the transaction announcement.
Nova will provide additional strategic, financial, and operational support, while Omiros Millas and Carl Francis will work with the individual management teams on strategy, performance, investment, and development.
The announcement does not disclose any immediate changes to the businesses’ names, management structures or customer relationships.
Instead, the stated focus is on maintaining the capabilities that already exist while adding resources and investment.
Nova has also identified product innovation and operational improvement as areas that could contribute to future development.
For businesses operating across industrial manufacturing and specialist healthcare products, these areas can involve decisions around production processes, supply chains, product development, customer relationships and investment planning.
What does the acquisition mean for the UK corporate sector?
The acquisition brings together private equity ownership, UK manufacturing and specialist healthcare products in a single corporate transaction.
For Andrew Industries, the sale separates BMP Group and RB Medical from the wider privately owned multinational manufacturing group. For Nova, it expands its portfolio with businesses that the firm says have established technical capabilities and customer relationships.
The announcement does not disclose the acquisition price, financing structure or specific financial projections, so the immediate financial impact of the transaction cannot be assessed from the publicly released information.
What has been disclosed is Nova’s intended operating approach: retain existing management structures, work with current leadership teams, provide additional investment and pursue operational improvement and product innovation.
For the businesses themselves, the next phase will therefore involve implementing the new ownership structure while continuing their existing operations.
The transaction also demonstrates the role of specialist corporate advisers in UK diversified-industrials transactions. Dentons, Cooper Parry, Grant Thornton, Fellwood Advisory, KPMG Corporate Finance and DLA Piper were all identified in the announcement as advisers to the parties.
For professionals working across Management, corporate finance and transaction-related functions, the acquisition provides a case study in ownership transition, operational strategy, financial planning and post-acquisition development.
The transaction also touches areas covered by Legal, Contracts and Procurement, particularly because legal advisers and corporate-finance advisers were involved in the sale process and the acquired businesses operate through established commercial relationships.
As the acquired companies continue under their existing management structures, the emphasis described by Nova is on strategic planning, operational performance, investment and business development rather than an immediate overhaul of day-to-day leadership.
What are the next priorities for Nova, BMP Group and RB Medical?
The publicly announced priorities centre on continued investment, operational improvement, product innovation and long-term growth.
Nova has also said it intends to preserve the capabilities and customer relationships developed by the businesses while providing additional resources and focus.
Omiros Millas and Carl Francis will work with the respective management teams, creating a structure in which Nova’s investment and operational expertise is combined with existing leadership knowledge.
The companies’ future performance, investment levels and any further corporate changes will depend on how that strategy is implemented.
At the time of the announcement, however, the confirmed elements are the change in ownership, the continuation of existing management structures, the appointment of Nova representatives to oversee the businesses and Nova’s stated intention to invest in their future development.
The acquisition consequently represents a significant corporate transaction involving a long-established Lancashire-based manufacturing group, a private equity investor and two specialised businesses operating across industrial and healthcare markets. With transaction terms undisclosed, the clearest information currently available concerns the ownership change and the operating strategy announced by Nova and Andrew Industries.